(Q54525376)

30 May 2018

title

Prolactin promotes hepatocellular carcinoma through Janus kinase 2. (English)

1 reference

30 May 2018

main subject

hepatocellular carcinoma

1 reference

Yao-Tsung Yeh

1

1 reference

30 May 2018

King-Teh Lee

2

1 reference

30 May 2018

Chia-Jung Tsai

3

1 reference

30 May 2018

Yu-Jie Chen

4

1 reference

30 May 2018

Shen-Nien Wang

5

1 reference

30 May 2018

publication date

1 May 2012

1 reference

30 May 2018

published in

World Journal of Surgery

1 reference

30 May 2018

volume

36

1 reference

30 May 2018

issue

5

1 reference

30 May 2018

page(s)

1128-1135

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1007/s00268-012-1505-4

exact match

0 references

cites work

Prolactin and growth hormone in fish osmoregulation

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Prolactin, psychological stress and environment in humans: adaptation and maladaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Expression and distribution of prolactin receptor in normal, fibrotic, and cirrhotic human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Cytokine induction of prolactin receptors mediates prolactin inhibition of nitric oxide synthesis in pulmonary fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

New mechanisms for PRLr action in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

The lifetime cost of hepatocellular carcinoma : a claims data analysis from a medical centre in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Serum adiponectin levels in cholesterol and pigment cholelithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Potential prognostic value of leptin receptor in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Aberrant expression and possible involvement of the leptin receptor in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Will GnRH antagonists improve prostate cancer treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Prolactin serum levels and breast cancer: relationships with risk factors and tumour characteristics among pre- and postmenopausal women in a population-based case-control study from Poland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Regulation of JAK-STAT signalling in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Nuclear cyclin D1: an oncogenic driver in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-012-1505-4

Prolactin and human tumourogenesis.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cellular distribution of prolactin receptors in human digestive tissues

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decreased expression of phosphorylated JNK in breast infiltrating ductal carcinoma is associated with a better overall survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22392353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00268-012-1505-4

1 reference

30 May 2018

1 reference

30 May 2018